KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

11.54

-0.39 (-3.27%)

Mar 31, 2025, 4:00 PM EDT - Market closed

KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Mar '25 Mar 31, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2019 - 2015
Market Capitalization	574	479	291	312	607	195	Upgrade
Market Cap Growth	-19.21%	64.29%	-6.71%	-48.53%	211.76%	-50.92%	Upgrade
Enterprise Value	326	411	128	126	558	116	Upgrade
Last Close Price	11.54	11.35	8.53	12.73	24.97	10.91	Upgrade
PS Ratio	-	-	-	-	15.34	Upgrade
PB Ratio	3.94	2.32	1.81	1.69	2.36	2.33	Upgrade
P/TBV Ratio	3.03	2.32	1.81	1.69	2.36	2.33	Upgrade
EV/Sales Ratio	-	-	-	-	9.11	Upgrade
Debt / Equity Ratio	0.04	0.04	0.05	0.04	0.02	0.02	Upgrade
Asset Turnover	-	-	-	-	-	0.12	Upgrade
Quick Ratio	10.25	9.70	11.18	15.81	26.67	10.91	Upgrade
Current Ratio	10.44	9.90	11.46	16.73	27.04	11.49	Upgrade
Return on Equity (ROE)	-150.50%	-68.90%	-53.69%	-37.23%	-27.13%	-32.26%	Upgrade
Return on Assets (ROA)	-58.15%	-41.94%	-35.80%	-25.38%	-19.86%	-24.05%	Upgrade
Return on Capital (ROIC)	-91.84%	-45.82%	-38.23%	-26.46%	-20.78%	-27.81%	Upgrade
Earnings Yield	-30.65%	-26.45%	-31.88%	-26.35%	-7.62%	-14.95%	Upgrade
FCF Yield	-22.28%	-18.64%	-26.23%	-25.31%	-4.98%	-23.13%	Upgrade
Buyback Yield / Dilution	-37.13%	-31.89%	-13.96%	-28.17%	-7.58%	-17.69%	Upgrade

Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q